Ulus Salih Akarca

Ulus Salih Akarca

Ege Üniversitesi

H-index: 47

Asia-Turkey

Contact Ulus Salih Akarca

About Ulus Salih Akarca

Ulus Salih Akarca, With an exceptional h-index of 47 and a recent h-index of 24 (since 2020), a distinguished researcher at Ege Üniversitesi, specializes in the field of Gastroenterology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Efficacy and safety of elafibranor in primary biliary cholangitis

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

TASL practice guidance on the clinical assessment and management of patients with nonalcoholic fatty liver disease

Psychometric tests, critical flicker frequency, and inflammatory indicators in covert hepatic encephalopathy diagnosis

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos (t) ide analogues for the treatment of chronic …

Ulus Salih Akarca Information

University	Ege Üniversitesi
Position	___
Citations(all)	14284
Citations(since 2020)	5587
Cited By	10767
hIndex(all)	47
hIndex(since 2020)	24
i10Index(all)	111
i10Index(since 2020)	44
Email	Access Email
University Profile Page	Ege Üniversitesi
Google Scholar	View Google Scholar Profile

Ulus Salih Akarca Skills & Research Interests

Gastroenterology

Top articles of Ulus Salih Akarca

Efficacy and safety of elafibranor in primary biliary cholangitis

New England Journal of Medicine

2024/2/29

Mario Reis Alvares-Da-Silva

H-Index: 14

Pietro Invernizzi

H-Index: 53

David Jones

H-Index: 43

Victor Vargas

H-Index: 2

Benjamin Miller

H-Index: 29

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

2024/2/14

Jh Kao

H-Index: 57

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

Journal of Hepatology

2024/2/1

E Ali

H-Index: 33

Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Liver International

2024/1

Ramazan Idilman

H-Index: 27

TASL practice guidance on the clinical assessment and management of patients with nonalcoholic fatty liver disease

Hepatology forum

2023

Yusuf Yilmaz

H-Index: 6

Mustafa Sahin

H-Index: 2

Ilker Turan

H-Index: 8

Funda Yilmaz

H-Index: 14

Ulus Salih Akarca

H-Index: 28

Murat Akyildiz

H-Index: 7

Nuray Yazihan

H-Index: 11

Engin Tutar

H-Index: 5

Yasemin Balaban

H-Index: 9

Murat Kiyici

H-Index: 10

Musturay Karcaaltincaba

H-Index: 23

Kadir Demir

H-Index: 5

Sadi Gulec

H-Index: 24

Halis Simsek

H-Index: 11

Mehmet Demir

H-Index: 2

Psychometric tests, critical flicker frequency, and inflammatory indicators in covert hepatic encephalopathy diagnosis

Hepatology Forum

2023/1

Timur Kose

H-Index: 22

Ilker Turan

H-Index: 8

Ulus Salih Akarca

H-Index: 28

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

The Lancet Gastroenterology & Hepatology

2023/10/1

Thomas Berg

H-Index: 5

Young-Suk Lim

H-Index: 48

Soo Aleman

H-Index: 20

Hugo Cheinquer

H-Index: 17

Kent Jason Cheng

H-Index: 3

Fernando Contreras

H-Index: 1

Chris Cunningham

H-Index: 7

Olav Dalgard

H-Index: 28

Robert De Knegt

H-Index: 16

Paulo Ferreira

H-Index: 22

Irsan Hasan

H-Index: 13

Angelos Hatzakis

H-Index: 39

Javier Hernandez

H-Index: 2

Jerzy Jaroszewicz

H-Index: 3

Aamir Khan

H-Index: 5

Martin Lagging

H-Index: 21

Pietro Lampertico

H-Index: 36

Alice Lee

H-Index: 12

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos (t) ide analogues for the treatment of chronic …

The Lancet Gastroenterology & Hepatology

2023/9/1

Oliver Lenz

H-Index: 31

Brian Conway

H-Index: 10

Scott Fung

H-Index: 8

Dominique Guyader

H-Index: 33

Pietro Lampertico

H-Index: 36

Kei Fujiwara

H-Index: 15

Jung-Hwan Yoon

H-Index: 3

Young-Suk Lim

H-Index: 48

Rosmawati Mohamed

H-Index: 24

Tatiana Stepanova

H-Index: 2

Pisit Tangkijvanich

H-Index: 22

Tawesak Tanwandee

H-Index: 24

Ulus Salih Akarca

H-Index: 28

Murat Akova

H-Index: 47

Ramazan Idilman

H-Index: 27

David Bell

H-Index: 34

Patrick Kennedy

H-Index: 7

Kevin Korenblat

H-Index: 21

Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2a treatment of hepatitis D: An analysis of the HIDIT‐II trial

Liver International

2023/8

Ramazan Idilman

H-Index: 27

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV-and high-HBV/HDV-prevalence countries

Journal of Hepatology

2023/8/1

Soo Aleman

H-Index: 20

Thomas Berg

H-Index: 5

Hugo Cheinquer

H-Index: 17

Martin Lagging

H-Index: 21

Young-Suk Lim

H-Index: 48

Frank Tacke

H-Index: 77

Ming-Lung Yu

H-Index: 39

Five years follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Journal of Hepatology

2023/6/1

George Papatheodoridis

H-Index: 49

Ramazan Idilman

H-Index: 27

Comparison of Liver Transplant Outcomes in Biliary Atresia Patients, Considering Whether They Underwent the Kasai Procedure Beforehand: A Single Center Analysis of 72 Patients

Transplantation Proceedings

2023/6/1

Veysel Umman

H-Index: 5

Ulus Salih Akarca

H-Index: 28

The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort

Hepatology Forum

2023

Mehmet Demir

H-Index: 2

Ilker Turan

H-Index: 8

Murat Akyildiz

H-Index: 7

Ulus Salih Akarca

H-Index: 28

Ramazan Idilman

H-Index: 27

Characteristics of patients with hepatocellular carcinoma: A multicenter study

Hepatology forum

2022/9

Engin Altintas

H-Index: 11

Coskun Ozer Demirtas

H-Index: 4

Cem Simsek

H-Index: 8

Ilker Turan

H-Index: 8

Mehmet Demir

H-Index: 2

Halis Simsek

H-Index: 11

Ulus Salih Akarca

H-Index: 28

Ramazan Idilman

H-Index: 27

Karaciğer biyopsisi endikasyonlarında ve histopatolojik tanılarda yıllar içindeki değişim: 7 yıllık tek merkez deneyimi

Akademik Gastroenteroloji Dergisi

2022/8/8

Fulya Günşar

H-Index: 12

Funda Yilmaz

H-Index: 14

İlker Turan

H-Index: 1

Ulus Salih Akarca

H-Index: 28

A single-center experience: Liver biopsy results during a year

Hepatology Forum

2022/5

Murat Akyildiz

H-Index: 7

Funda Yilmaz

H-Index: 14

Ulus Salih Akarca

H-Index: 28

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

2022/5/1

Frank Tacke

H-Index: 77

Soo Aleman

H-Index: 20

Hugo Cheinquer

H-Index: 17

Kent Jason Cheng

H-Index: 3

Olav Dalgard

H-Index: 28

Keshab Deuba

H-Index: 11

Sameera Ezzat

H-Index: 16

Angelos Hatzakis

H-Index: 39

Jerzy Jaroszewicz

H-Index: 3

Martin Lagging

H-Index: 21

Young-Suk Lim

H-Index: 48

Abstract Book

Hepatology Forum

2022/1/1

Eliminating Viral Hepatitis in Turkey: Achievements and Challenges

2022

Nurcan Baykam

H-Index: 14

Fulya Günşar

H-Index: 12

Baseline characteristics associated with survival in patients with hepatocellular carcinoma

Hepatology Forum

2022/1

Seymur Aslanov

H-Index: 0

Nalan Gulsen Unal

H-Index: 3

Alper Uysal

H-Index: 7

Murat Akyildiz

H-Index: 7

Ilker Turan

H-Index: 8

Ulus Salih Akarca

H-Index: 28

See List of Professors in Ulus Salih Akarca University(Ege Üniversitesi)

academic-engine

Useful Links

List of top 50 universities

List of top 100 universities

List of top 500 universities

Find Professors Email

Find Universities Email

CUFinder Academic Engine